Three distinct mechanism for regualting the HMG-CoA reductase
are:
- Transcription: The transcription og the
reductase gene is enhanced the sterol regulatory element binding
protein(SREBP). The protein binds at the sterol
regulatory element(SRE), which is found at the 5'
end of the gene after the controlled proteolytic processing. In its
inactive state SREBP is bound to ER or the nuclear membrane along
with another protein known as the SREBP cleavage-activating
protein(SCAP). SCAP when senses low cholesterol concentration it
transports SREBP to the Golgi membrane. Here after consecutive
proteolysis carried out by S1P and S2P, SREBP is cleaved into an
active form: nSREBP. These nSREBP's now migrate to
the nucleus and activate the transcription of SRE-containing genes.
nSREBP are short lived transcription factors. Once the cholestrol
level rises, Insigs retains the SCAP-SREBP complex in the ER, by
preventing it from incorporating in the COPII vesicles.
- Degradation: If the level of sterol in the
body is rising, the susceptibility of reductase enzyme to
ER-associated degradation and proteolysis also increases.Helixes 2
to 6 of the enzyme's transmembrane domain are considered to sense
the increasing level of cholestrol. Lysine residues get ubiquinated
by E3 ligases and hence its degradation
follows.
- Phosphorylation: This is the short term
pathway for the regulation of HMG-CoA reductase enzyme. It is
phosphorylatyed and inactivated by the action of an
AMP-activated protein kinase. Phosphorylation and
inactivation of acetyl-CoA carboxylase also occurs through this
protein kinase; Thus acetyl CoA is utilized in both the pathways
vor lipid synthesis, when energy charge is low in cells and AMP
concentration rises.